NOTTO Transplant Specific Guidelines with Reference to COVID-19

Vivek Kute; Sandeep Guleria; Jai Prakash; Sunil Shroff; Narayan Prasad; Sanjay K Agarwal; Santosh Varughese; Subhash Gupta; A G K Gokhale; Manisha Sahay; Ashish Sharma; Prem Varma; Anil Bhalla; Harsh Vardhan; Manish Balwani; Shruti Dave; Dhamendra Bhadauria; Manish Rathi; Dhananjay Agarwal; Pankaj Shah; Vasanthi Ramesh; Rajiv Garg

doi:10.4103/ijn.IJN_299_20

View/Download PDF

Buy Reprints

PDF

Translate this page into:

Special Article

30 (

4

); 215-220

doi:

10.4103/ijn.IJN_299_20

NOTTO Transplant Specific Guidelines with Reference to COVID-19

Vivek Kute, Sandeep Guleria¹, Jai Prakash², Sunil Shroff³, Narayan Prasad⁴, Sanjay K Agarwal⁵, Santosh Varughese⁶, Subhash Gupta⁷, A G K Gokhale⁸, Manisha Sahay⁹, Ashish Sharma¹⁰, Prem Varma¹¹, Anil Bhalla¹², Harsh Vardhan¹³, Manish Balwani¹⁴, Shruti Dave¹⁵, Dhamendra Bhadauria¹⁶, Manish Rathi¹⁷, Dhananjay Agarwal¹⁸, Pankaj Shah¹⁹, Vasanthi Ramesh²⁰, Rajiv Garg²¹

Department of Nephrology, Institute of Kidney Diseases and Research Center and Dr. H L Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India

1Department of Transplantation Surgery, Apollo Hospital, New Delhi, India

2Banaras Hindu University, Varanasi, Utter Pradesh, India

3MOHAN Foundation, Chennai, India

4Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Utter Pradesh, India

5Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India

6Department of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India

7Department of liver transplant surgery, Max Center of Liver and Biliary Sciences at Max Hospital, Saket, New Delhi, India

8Department of Heart & Lung Transplant Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India

9Department of Nephrology, Osmania Medical College, Hyderabad, Telangana, India

10Department of Transplant Surgery, The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

11Department of Nephrology, Venkateshwar Hospital, New Delhi, India

12Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, India

13Department of Nephrology, Indira Gandhi Institute of Medical Science, Patna, Bihar, India

14Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India

15Department of Pathology, IKDRC-ITS, Ahmedabad, Gujarat, India

16Department of Nephrology, SGPGI, Lucknow, Utter Pradesh, India

17Department of Nephrology, PGIMER, Chandigarh, India

18Department of Nephrology, SMS Hospital, Jaipur, Rajasthan, India

19Department of Nephrology, IKDRC-ITS, Ahmedabad, Gujarat, India

20National Organ and Tissue Transplant Organization, Department of Surgery, VMMC and Safdarjung Hospital, New Delhi, India

21Director General Health Services, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi, India

Address for correspondence: Dr. Vasanthi Ramesh, National Organ & Tissue Transplant Organization, NIOP Building, Safdarjung Hospital Campus, New Delhi, India. E-mail: dir@notto.nic.in

Received: 2020-06-23, Accepted: 2020-07-17, Published: 2020-08

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

Introduction

Novel corona virus (SARS-CoV-2) infection starting since December 2019 has resulted in pandemic within few weeks’ time. In addition to elderly and patients with associated comorbidities, organ transplant recipients are at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection. Further, there is potential risk of infection transmission from the donor to recipient through organ transplantation. Also, there are issues in recipient and donor selection for transplant. In view of these issues, organ transplant at the time of COVID-19 pandemic should be undertaken with caution. The optimal approach to corona virus disease (COVID-19) screening in organ recipients and donors may change over time as more data accumulate.[1 2 3]

Organ transplantation for end stage organ failure can be a lifesaving intervention in patients with organ failure and mostly can be performed electively with few exceptions. Patients with acute liver failure, acute on chronic liver failure, and those with hepatocellular cancer need an urgent transplant. Some countries have stopped living donor organ transplants (with exception for life saving measures) while some continue with deceased donor organ transplantation. However, due to risk of COVID-19-related morbidity and mortality in the recipient and living donor and cross infection of COVID-19 among other patients and health care workers (HCW), there is need for assessing the overall risk v/s benefit of organ transplantation. If in certain organs the risk of death is higher due to waiting then that patient should be considered for organ transplantation. As the situation improves, there may need to be a phased increment in transplantation services. It may be prudent to limit transplants to those who are struggling with non-transplant modalities of treatment.

The risk-benefit ratio should be the key point to be exercised in deciding the need for transplantation as post-transplant these patients will be kept on immunosuppressive drugs which will make them prone to acquiring covid-19 infection.

All transplant teams can quickly build up a database and assess regarding number of patients currently contactable, their ability to procure medicines in the current lockdown and connectivity with their doctors, number of patients who developed COVID-19, and their outcome. This will help each of the regions to set up support systems not only for already transplanted patients but also for the new transplants.

While recommending organ transplantation during COVID-19 pandemic, following general safeguards have to be ensured by each hospital:

Safety of health care professionals (doctors, nurses, coordinators, technicians, hospital attendants, housekeeping staffs, ambulance drivers) by providing required PPE as per their risk stratification
Prevention of transmission of COVID-19 from patients (recipients and donors) to HCWs and vice-versa by having proper facilities for universal precaution including isolation in pre and post-transplant period.
Prevention of cross infection of COVID-19 from these patients (recipients and donors) to other non-transplant patients.

General Precautions

Before restarting transplant program in the era of COVID-19, we recommend that each transplant hospital does a detailed assessment of epidemiology, current trends, surge capacity and impact of COVID-19 as well as assessment of ICU facility and team in respective hospitals. Only after that, transplant can proceed with caution if the above concerns have been addressed.
Before transplanting new patient, we suggest to initiate assessment of existing transplant recipients for their access to drugs. Patients transplanted in COVID-19 pandemic should have the same stringent follow up as they would have got prior to it.
We suggest a team of HCW (transplant coordinators and transplant team members) should be designated to care EXCLUSIVELY for transplant cases (COVID FREE safe transplant pathway) to reduce the risk of transmission. When feasible all transplant teams should define two teams which are separate and not working together and which should have independent transplant surgeon, physician and intensivist so that all surgical and medical problems can be handled if one team gets quarantined or exposed. The teams can alternate for each patient. Transplant teams should reserve personnel at all levels so that in case a member needs quarantine on account of COVID-19 infection, the care of the patient should not suffer. Alternatively, an informal understanding should take place between transplant centres in the same city to provide cross over in such an eventuality
We recommend all transplant recipients and donors should sign the fully documented written informed CONSENT accepting a potential risk of COVID-19 infection during hospital stay and after transplant. It should include risk and benefit of transplantation vs available alternative treatment such as dialysis in case of renal failure.
We recommend adequate availability of personal protective equipment (PPE) (i.e., triple layer masks, N95 respirators (preferably without valves), gloves, gowns, goggles, face shields, shoes/shoe covers) as per GOVERNMENT guidelines.[1 2]
We recommend routine training of HCW on use and disposal of PPE.[1 2] [Tables 1 and 2].
We recommend ensuring HCW should receive adequate required training on various component of “universal precautions” (hand hygiene, respiratory etiquette, and social distancing, etc.)[1 2]

Table 1 Transplant unit preparedness checklist to deliver safe transplant during and after COVID-19 pandemic

Checklist for transplantation	Donor	Recipient	HCW	Care Givers
1) Social distancing: Practicing social distancing for 14 days prior to surgery to avoid unnecessary exposure	Yes/No	Yes/No	Yes/No	Yes/No
2) Health education on COVID-19 prevention	Yes/No	Yes/No	Yes/No	Yes/No
3) COVID-19 Diagnosis
Epidemiological screening for travel and potential exposures
Travel to or residing in an area in the preceding 21 days, where local COVID-19 transmission is occurring	Yes/No	Yes/No	Yes/No	Yes/No
Direct contact with known or suspected case of COVID-19 in the preceding 21 days	Yes/No	Yes/No	Yes/No	Yes/No
Confirmed Diagnosis of COVID 19 in the last 28 days	Yes/No	Yes/No	Yes/No	Yes/No
Travel to or residing in an area which has been designated as a containment zone in the last 28 days	Yes/No	Yes/No	Yes/No	Yes/No
Any suspicion to conceal history of exposure to COVID-19 in patient and donor in order to receive transplant	Yes/No	Yes/No	NA	NA
CLINICAL screening for COVID-19 symptoms
History of fever (>38°C or 100.3°F) and or	Yes/No	Yes/No	Yes/No	Yes/No
Respiratory symptoms: Cough shortness of breath, wheezing or chest tightness, sore throat, flu like symptoms. Consider excluding symptoms attributable to other causes and allergies	Yes/No	Yes/No	Yes/No	Yes/No
Temperature (thermal screening)	Yes/No	Yes/No	Yes/No	Yes/No
Laboratory screening with COVID-19 RT-PCR test of airway specimen (1-3 days before transplant)			If required or hospital is a COVID facility
Date and time
Specimen used: nasopharyngeal, oropharyngeal swab, bronchoalveolar lavage, endotracheal aspirate or a combination
Results	+ve/-ve	+ve/-ve	+ve/-ve	+ve/-ve
4) Potential risk of COVID-19 consent: have transplant recipient and donor signed an informed consent accepting a potential risk of COVID-19 infection in hospital and after transplant?			NA
5) Other Optional Tests if suggested by the transplant team
CT chest
Date and time
Results : normal/suspicious of COVID-19
LABORATORY screening (COVID-19 RT-PCR test of airway specimen) (second test such as in hot spot)
Date and time
Specimen used
Results
PCR every week during their stay and before discharge
COVID-19 IgM/IgG antibody rapid test if approved by the government
Pro-calcitonin
Highly reactive C reactive protein
Complete blood count: lymphocyte count
6) COVID-19 assessment Acceptable To Proceed for surgery	Yes/No	Yes/No	Yes/No	Yes/No
Date and time of proposed surgery
Is laboratory testing compatible with proposed transplant date and time?	Yes/No	Yes/No	Yes/No	Yes/No
Remark
Date: Name/Signature

This checklist should be used in conjunction with policies and official guidance from local health authorities or hospitals

Table 2 Check list for transplant unit

Is there enough stock of PPE and drugs?	Yes/No
Are all HCW patients, attendants and caregivers wearing a three-layer surgical facemask inside the pre and post-transplant area?	Yes/No
Is training for use of PPE including donning, doffing and proper disposal is completed for HCW?	Yes/No
Have HCW received training in updated clinical knowledge of COVID-19 & guidelines from government, academic society, and hospital authority, cough etiquette, hand hygiene, social distancing, PPE and universal precautions?	Yes/No
Have HCW received training for clinical, epidemiology, laboratory screening of patients, donors, care takers and COVID consent process?	Yes/No
Have HCW self-monitored their symptoms and informed transplant program head in case they or their family members develop symptom(s) suggestive of COVID-19?	Yes/No
Is list of staff recorded and be retained by transplant team head?	Yes/No
Have HCW had meals at different times after washing hands with flowing water?	Yes/No
COVID FREE SAFE PATHWAY FOR TRANSPLANT	Yes/No
Is there a designated entry and exit for patients and HCW involved in transplant?	Yes/No
Is there a dedicated area for pre-transplant evaluation to maintain distance between patients, donors and health workers, and is it cleaned between sessions?	Yes/No
Is cleaning and disinfection time table of pre-transplant area displayed at entry gate?	Yes/No
PRE AND POST-TRANSPLANT OPD AND WARD	Yes/No
Is there an alcohol-based hand sanitizer at entry?	Yes/No
Are the following equipment either used separately for each patient OR disinfect between the shifts?	Yes/No
Stethoscopes (diaphragms and tubing cleaned with an alcohol based disinfectant)	Yes/No
BP cuffs (NIBP cuffs can be cleaned by alcohol or 1% sodium hypochlorite)	Yes/No
Oxygen saturation probes	Yes/No
No sharing of thermometers	Yes/No
Are posters displayed on education and preventions of COVID-19 (hand hygiene, social distancing, COVID-19 symptoms and testing and universal precautions)?	Yes/No
Transplant infectious disease assessment if required	Yes/No
Transplant psychiatry assessment if required	Yes/No
Are disinfection, environmental cleanliness, and good air conditioning & ventilation conditions instituted?	Yes/No
Is social distancing followed?	Yes/No
Are all frequently touched surfaces inside the transplant unit, cleaned and disinfected frequently and duty list maintained?	Yes/No
Transplant OT	Yes/No
Is there dedicated transplant OT and HCW for surgery?	Yes/No
Is there cleaning and disinfection of OT and timetable?	Yes/No
Post-Transplant	Yes/No
Post-transplant patient and donor in separate rooms with an attached bathroom	Yes/No
Are visitors limited to one visitor for 10 minutes with social distancing (2 meter), wearing a surgical mask and a gown?	Yes/No
Determine approaches to minimize exposure to the healthcare setting for non-essential services	Yes/No
Is telemedicine and emergency consultation contact number available?	Yes/No
Recipients should avoid travel to area with COVID-19 cases	Yes/No
Can patients find information about the latest developments regarding COVID-19 on the hospital and government website? visit https://www.mohfw.gov.in/	Yes/No
Remark : Date: Name/Signature

Recipient and Donor Related

8. We recommend haemodialysis unit preparedness and safe dialysis delivery based on the Government of India guidelines for dialysis before transplant.[4 5]

9. We recommend routine CLINICAL and EPIDEMIOLOGICAL screening for COVID-19 in donors, recipients, HCW and care takers[6 7 8] [Tables 1 and 2].

CLINICAL screening: fever (>38°C or 100.3°F) and/or respiratory symptoms (cough, shortness of breath, wheezing or chest tightness), anosmia, sore throat, flu-like symptoms.
EPIDEMIOLOGICAL:

Travel to or residing in an area in the preceding 21 days, where localCOVID-19 transmission is occurring
Confirmed diagnosis of COVID-19 in the last 28 days
Direct contact with known or suspected case of COVID-19 in the preceding 21 days.
Travel to or residing in an area which has been designated as a containment zone in the last 28 days.

10. We recommend routine LABORATORY screening with COVID-19 real time polymerase chain reaction (RT-PCR) test of airway specimen for both donor and recipient with the testing occurring as close as possible prior to surgery within 24–72 hours in both living and deceased donor organ transplants. Chest CT scan of the donor is mandatory prior to lung transplantation and may also be required in other transplants for donor and/or recipient if suggested by the transplant team.[9 10]

11. Living donor with positive COVID-19 test should not donate for at least 3–6 months until the long-term outcome of cured COVID-19 becomes clear. However, in case of life saving transplants, we suggest accepting donor with a previous diagnosis of COVID-19 with documented two negative COVID-19 tests and complete symptom resolution for 28 days and another negative test at the time of donation.

12. We suggest practicing social distancing for 14 days prior to surgery for both living donor and recipient and using surgical facemask when going out in public

13. We recommend minimizing the use of energy devices during procedures when possible. When energy is needed, we recommend avoiding the ultrasonic scalpel and lower energy settings to minimize surgical smoke.

14. We suggest use of induction and other immunosuppressive drugs based on recipient's own immune risk stratification as being practised before COVID-19.

15. We suggest restricting movement of recipient to other hospital areas. Use designated portable X-ray equipment and/or other designated diagnostic equipment. If transport is mandatory, use predetermined transport routes to minimize exposure to staff, other patients, and visitors, and patient must use surgical mask. Ensure that HCWs who are transporting patients perform hand hygiene and use surgical mask.

16. We recommend limiting visitors to those essential for patient support and visitor use surgical mask and keep social distancing. Visitor's records should be maintained for contact tracing if required in future.

17. We suggest managing laboratory specimens, laundry, food service utensils, and medical waste following safe routine procedures according to infection prevention control guidelines.

18. We recommend use of disposable equipment as far as possible or if equipment (e.g., stethoscopes, blood pressure cuffs, thermometers, food trays) need to be re-used, then clean and disinfect between use for each patient (e.g., by cleaning with ethyl alcohol 70% or 1% sodium hypochlorite).

19. We recommend routine cleaning and disinfecting surfaces with which the patient is in contact with 1% sodium hypochlorite solution.

20. If recipient and/or donor become COVID-19 positive, we suggest treatment as per local authority guidelines as currently there is no standard accepted treatment guidelines. There is no consensus regarding modification in immunosuppressive regimen. Transplant team should make a CASE BY CASE evaluation for dose adjustment to balance infection control & rejection.

21. We suggest telemedicine for encouraging social distancing when feasible. Telemedicine consultation is not a substitute to in-person consultation where clinical examination is required.

22. We suggest using AarogyaSetuApp, taking extra care of the elderly, healthy lifestyle for all, and strict adherence to universal precautions all the time to mitigate the spread of COVID-19.

23. We recommend these guidelines and checklist should be used in conjunction with local policies and official guidance from health authorities or hospitals as per changing situation.

24. We recommend that all infection prevention and control measures shall be implemented.

25. In order to ensure monitoring the compliance to guidelines, State appropriate authority, concerned SOTTO and ROTTO should monitor compliance to the guidelines through seeking detailed data from the hospitals in this regard and sharing the same with NOTTO on regular basis.

Futuristic approach for COVID-19 testing protocol for planned surgery- The patients should get admitted in isolation 24 hours before planned surgery [Table 3][11]

Table 3 COVID tests and action required for transplantation

RTPCR	IgM	IgG	Action proposed
Negative		Positive	May be taken for transplantation, no testing during hospital stay and exit test
Negative	Negative	Negative	No infection- Go for transplantation, PCR testing every 6-7 days of stay and exit PCR test
Positive	Negative		Defer transplantation till PCR negative & IgG appears

At present, there is no recommendation for prophylactic medications such as hydroxychloroquine for transplant patients.

Conclusion

Given that the epidemiological situation is constantly evolving, it is recommended that each transplant team assess the current scenario that best describes their local situation.[6 12] Any transplant program should make a CASE BY CASE evaluation when assessing the convenience of carrying out a transplant based on availability of health care resources including ICU; risk/benefit of exposing an immunosuppressed patient to the potential risk of COVID-19 (according to the number of cases and the possibility of admission under ideal isolation conditions) versus the urgent medical need for transplantation (clinical situation of the patient).

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Acknowledgements

NOTTO wishes to thank members of the Indian Society of Transplantation (ISOT), Liver Transplant Society of India (LTSI) and the Indian Society for Heart and Lung Transplantation (INSHLT) for their expert input, critical review, and approval of this statement. The authors have not received any funding or grants in support of the presented research or for the preparation of this work and have no potential declarations of interest.

References

Available from: https://www.mohfw.gov.in/.
WHO. Available from: https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019
ECDC. Available from: https://wwwecdceuropaeu/en/publicationsdata/risk-assessment-outbreak-acute- respiratory-syndrome-associatednovel-1
Available from: https://www mohfwgovin/pdf/Guidelinesfor DialysisofCovid19Patientspdf
Available from: https://cdn.georgeinstitute.org/sites/default/files/ covid19-hemodialysis-unit-preparedness-checklist.pdf.
Ahn C, Amer H, Anglicheau D, Ascher N, Baan C, Bat-Ireedui, . Global transplantation COVID report March 2020. Transplantation 2020 doi: 101097/TP 0000000000003258
[Google Scholar]
Available from: https://notto.gov.in/WriteReadData/Portal/ News/711_1_FINAL_GUIDANCE_COVID-19_31.03.2020. pdf
Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, . Liver transplantation and COVID-19 (Coronavirus) infection: Guidelines of the liver transplant Society of India (LTSI) Hepatol Int. 2020;14:429-31.
[Google Scholar]
D’Andrea A, Di Giannuario G, Marrazzo G, Riegler L, Mele D, Rizzo M, . The role of multimodality imaging in COVID-19 patients: From diagnosis to clinical monitoring and prognosis] G ItalCardiol (Rome) Italian. 2020;21:345-53.
[Google Scholar]
Zhou S, Wang Y, Zhu T, Xia L, . CT Features of coronavirus disease 2019(COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J Roentgenol. 2020;214:1287-94.
[Google Scholar]
Al-Muharraqi MA, . Testing recommendation for COVID-19 (SARSCoV-2) in patients planned for surgery-continuing the service and 'suppressing’ the pandemic. Br J Oral Maxillofac Surg 2020 doi: 101016/jbjoms 202004014
[Google Scholar]
Martino F, Plebani M, Ronco C, . Kidney transplant programmes during the COVID-19 pandemic. Lancet Respir Med. 2020;8:e39.
[Google Scholar]